Acurx Pharmaceuticals

ACXP · NASDAQ · Pharmaceutical Preparations

Acurx Pharmaceuticals (ACXP) · oqro.io/stocks/ACXP · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.

How this filing works

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at ACXP buy and sell in the last 90 days?Which members of Congress and which funds traded ACXP recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

Insider trades around earnings

6 open-market purchases and 0 open-market sales by insiders of ACXP between Jul 10, 2024 and today, placed against the company's last 4 earnings releases. The latest on file was filed May 13, 2025. The data provider lists the next release for Mar 10, 2027; that date may change.

PurchaseSale30 days before a release30 days after

Trades in the 30 days around each of the last earnings releases
Earnings release	30 days before	On the day	30 days after
May 13, 2025	None	None	None
Mar 18, 2025	None	None	None
Nov 13, 2024	None	None	None
Aug 9, 2024	None	None	None

Joseph C Scodari, Director, Jan 6, 2025, about $25K. Bought 54 days after the company's previous earnings release on 2024-11-13Form 4
Carl Sailer, Director, Jan 6, 2025, about $25K. Bought 54 days after the company's previous earnings release on 2024-11-13Form 4
David P Luci, President and CEO, Jan 6, 2025, about $50K. Bought 54 days after the company's previous earnings release on 2024-11-13Form 4
James J. Donohue, Director, Jan 6, 2025, about $10K. Bought 54 days after the company's previous earnings release on 2024-11-13Form 4
, Director, Jan 6, 2025, about $50K. Bought 54 days after the company's previous earnings release on 2024-11-13

Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies

Insider trades · 6

8 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them

Insider buying

David P LuciPresident and CEO

Filed 2y ago

Bought

~$50K49K sh @ $1.02

Traded Jan 6, 2025 · filed 2 days later

The CEO of Acurx Pharmaceuticals paid $50K out of pocket for Acurx Pharmaceuticals shares. 5 other people at Acurx Pharmaceuticals bought some too, in the same month.

More Official record

Insider buying

Carl SailerDirector

Filed 2y ago

Bought

~$25K25K sh @ $1.02

Traded Jan 6, 2025 · filed 2 days later

An Acurx Pharmaceuticals director paid $25K out of pocket for Acurx Pharmaceuticals shares. 5 other people at Acurx Pharmaceuticals bought some too, in the same month. Shares held went up 22% with this purchase.

More Official record

Insider buying

Joseph C ScodariDirector

Filed 2y ago

Bought

~$25K25K sh @ $1.02

Traded Jan 6, 2025 · filed 2 days later

More Official record

Insider buying

Jack H DeanDirector

Filed 2y ago

Bought

~$10K9,852 sh @ $1.02

Traded Jan 6, 2025 · filed 2 days later

An Acurx Pharmaceuticals director paid $10K out of pocket for Acurx Pharmaceuticals shares. 5 other people at Acurx Pharmaceuticals bought some too, in the same month. Shares held went up 83% with this purchase.

More Official record

Insider buying

James J. DonohueDirector

Filed 2y ago

Bought

~$10K9,852 sh @ $1.02

Traded Jan 6, 2025 · filed 2 days later

More Official record

Insider buying

Robert J DelucciaDirector

Filed 2y ago

Bought

~$50K49K sh @ $1.02

Traded Jan 6, 2025 · filed 2 days later

An Acurx Pharmaceuticals director paid $50K out of pocket for Acurx Pharmaceuticals shares. 5 other people at Acurx Pharmaceuticals bought some too, in the same month. Shares held went up 5% with this purchase.

More Official record